119 related articles for article (PubMed ID: 8109847)
1. Interaction of diltiazem and rapamycin on survival of rat cardiac allografts.
Dumont L; Chen H; Xu D; Daloze P
Ann N Y Acad Sci; 1993 Nov; 696():392-5. PubMed ID: 8109847
[No Abstract] [Full Text] [Related]
2. Synergistic activity of the triple combination: cyclosporine, rapamycin, and brequinar.
Stepkowski SM; Kahan BD
Transplant Proc; 1993 Jun; 25(3 Suppl 2):29-31. PubMed ID: 8516939
[No Abstract] [Full Text] [Related]
3. Donor pretreatment with methylprednisolone synergistically prolongs survival of cardiac allografts in sensitized rat recipients conditioned with rapamycin.
Schmidbauer G; Homeyer A; Bohle RM; Grimm H; Binder J; Kupiec-Weglinski JW
Transplant Proc; 1997; 29(1-2):607-8. PubMed ID: 9123151
[No Abstract] [Full Text] [Related]
4. In vivo use of rapamycin suppresses neither IL-2 production nor IL-2 receptor expression in rat transplant model.
Hamashima T; Yoshimura N; Ohsaka Y; Oka T; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Feb; 25(1 Pt 1):723-4. PubMed ID: 8438457
[No Abstract] [Full Text] [Related]
5. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
[No Abstract] [Full Text] [Related]
6. Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
Mohacsi PJ; Joshi A; Wang J; Morris RE; Billingham ME
Transplant Proc; 1994 Dec; 26(6):3255-9. PubMed ID: 7998133
[No Abstract] [Full Text] [Related]
7. Interaction between rapamycin and pretransplant blood transfusions in rat heterotopic heart transplantation.
Tucker MJ; Duplan J; Li X; Garcia B; Wijsman J; Stiller C; McKenzie FN
Transplant Proc; 1993 Feb; 25(1 Pt 1):725-6. PubMed ID: 8438458
[No Abstract] [Full Text] [Related]
8. Immunosuppressive properties of the benzothiazepine calcium antagonists diltiazem and clentiazem, with and without cyclosporine, in heterotopic rat heart transplantation.
Dumont L; Chen H; Daloze P; Xu D; Garceau D
Transplantation; 1993 Jul; 56(1):181-4. PubMed ID: 8333040
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski SM; Kahan BD
Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
[No Abstract] [Full Text] [Related]
10. Effects of the pharmacokinetic interaction between orally administered sirolimus and cyclosporine on the synergistic prolongation of heart allograft survival in rats.
Stepkowski SM; Napoli KL; Wang ME; Qu X; Chou TC; Kahan BD
Transplantation; 1996 Oct; 62(7):986-94. PubMed ID: 8878394
[TBL] [Abstract][Full Text] [Related]
11. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Smith S; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
[No Abstract] [Full Text] [Related]
12. Rapamycin-induced long-term allograft survival depends on persistence of alloantigen.
Chen H; Luo H; Daloze P; Xu D; Wu J
J Immunol; 1994 Mar; 152(6):3107-18. PubMed ID: 8144906
[TBL] [Abstract][Full Text] [Related]
13. Rapamycin treatment prevents and/or erases sensitization and abrogates accelerated rejection of vascularized organ allografts.
Schmidbauer G; Hancock WW; Wasowska BA; Sablinski T; Kupiec-Weglinski JW
Transplant Proc; 1993 Feb; 25(1 Pt 1):712-3. PubMed ID: 8438450
[No Abstract] [Full Text] [Related]
14. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
Stepkowski SM; Chen H; Daloze P; Kahan BD
Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
[No Abstract] [Full Text] [Related]
15. Route of administration determines the efficacy of rapamycin but not the mechanisms of tolerance induced by it in rats.
Lin Y; Rutgeerts O; Waer M
Transplant Proc; 1996 Dec; 28(6):3057. PubMed ID: 8962185
[No Abstract] [Full Text] [Related]
16. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
[TBL] [Abstract][Full Text] [Related]
17. Effect of cyclosporine alone or in combination with rapamycin and brequinar on survival of hamster heart xenograft in rats.
Wang M; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1993 Oct; 25(5):2876-7. PubMed ID: 8212271
[No Abstract] [Full Text] [Related]
18. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Chen H; Wu J; Luo H; Daloze P
Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
[No Abstract] [Full Text] [Related]
19. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat.
Chen H; Xu D; Qi S; Wu J; Luo H; Daloze P
Transplantation; 1995 Apr; 59(8):1084-9. PubMed ID: 7732551
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin prolongs survival of murine recipients of fully allogeneic donor grafts when administered during the graft-versus-host disease process.
Blazar BR; Taylor PA; Sehgal SN; Vallera DA
Ann N Y Acad Sci; 1993 Jun; 685():73-85. PubMed ID: 8363278
[No Abstract] [Full Text] [Related]
[Next] [New Search]